Quadrivalent Inactivated Influenza Vaccine

BIOLOGICAL3 trials

Sponsors

Vanderbilt-Ingram Cancer Center, Duke University, Carlo Contreras

Conditions

Adverse Event Following ImmunisationBirth OutcomesClinical Stage I Cutaneous Melanoma AJCC v8Clinical Stage IA Cutaneous Melanoma AJCC v8Clinical Stage IB Cutaneous Melanoma AJCC v8Clinical Stage II Cutaneous Melanoma AJCC v8Clinical Stage IIA Cutaneous Melanoma AJCC v8Clinical Stage IIB Cutaneous Melanoma AJCC v8

Phase 1

Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma

RecruitingNCT04697576

Carlo ContrerasClinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8 +6

Start: 2021-10-20End: 2027-12-31Target: 36Updated: 2026-03-10

Phase 2

High vs. Standard Dose Flu Vaccine in Adult Stem Cell Transplant Recipients

CompletedNCT03179761

Vanderbilt-Ingram Cancer CenterHematopoietic Cell Transplantation

Start: 2017-10-09End: 2024-10-01Updated: 2024-12-04

Phase 4

Safety of RIV4 Versus IIV4 in Pregnant Women

CompletedNCT03969641

Duke UniversityAdverse Event Following Immunisation, Birth Outcomes, Safety

Start: 2019-09-05End: 2021-09-29Updated: 2023-01-11